Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

Bowman P, Sulen AE,Barbetti F,Beltrand J,Svalastoga P,Codner E, Tessmann EH, Juliusson PB,Skrivarhaug T, Pearson ER,Flanagan SE,Babiker T,Thomas NJ, Shepherd MH,Ellard S,Klimes I,Szopa M,Polak M,Iafusco D, Hattersley AT,Njolstad PR

Yearbook of Paediatric Endocrinology（2019）

Cited 102|Views0

No score

Abstract

This study describes a 10-year follow-up of a large international multicenter cohort of patients with KCNJ11 permanent neonatal diabetes. It addresses key questions relating to long-term efficacy and safety of sulfonylureas in these patients.

Translated text

Key words

neonatal diabetes,sulfonylureas,treatment,long-term

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined